De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients
Authors:
- 21 April 2011
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 39 (4) , 319-325
Abstract
The aim of this study was to examine the safety and efficacy of de-escalating antimicrobial therapy in immunocompetent patients presenting with bacteraemia due to antibiotic-sensitive pathogens.Keywords
This publication has 30 references indexed in Scilit:
- Could De-escalation of Antibiotic Therapy be Feasible Even for Documented Methicillin-Resistant Staphylococcus aureus Ventilator-Associated Pneumonia?Journal of Trauma: Injury, Infection & Critical Care, 2009
- Improving early management of bloodstream infection: a quality improvement projectBMJ, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2008
- Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 2007
- Principles of Antibiotic Therapy in Severe Infections: Optimizing the Therapeutic Approach by Use of Laboratory and Clinical DataClinical Infectious Diseases, 2007
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- De-escalation therapy in ventilator-associated pneumoniaCurrent Opinion in Critical Care, 2006
- De-escalation in lower respiratory tract infectionsCurrent Opinion in Pulmonary Medicine, 2006
- Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapyJournal of Antimicrobial Chemotherapy, 2004
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999